Echocardiography Monitoring during Anthracycline Administration in Hodgkin and Non-Hodgkin's Lymphoma: The Tei Index Evaluation.

Tei index cardiotoxicity echocardiography lymphoma personalized medicine

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
16 Feb 2022
Historique:
received: 27 12 2021
revised: 01 02 2022
accepted: 11 02 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 26 2 2022
Statut: epublish

Résumé

Anthracyclines are widely employed in lymphoma's chemotherapy and has been shown to induce heart failure. Echocardiographic parameters of left ventricular (LV) systolic function are usually used to monitor the cardiac side effects during and after anthracyclines treatment. The measurement of theTei index could anticipate the onset of LV dysfunction. The aim of this study was to evaluate the performance of the delta Tei index for the early detection of cardiac toxicity in a prospective population of anthracycline-treated lymphoma patients. Our preliminary data suggest that the Tei index may predict the risk for cardiotoxicity in this subset of patients earlier than LV ejection fraction alteration.

Identifiants

pubmed: 35207777
pii: jpm12020290
doi: 10.3390/jpm12020290
pmc: PMC8880655
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Eur Heart J. 2016 Jun 1;37(21):1642-50
pubmed: 26417058
J Cardiol. 1995 Aug;26(2):135-6
pubmed: 7674144
J Postgrad Med. 2002 Jul-Sep;48(3):206-8
pubmed: 12432198
Am J Cardiol. 2000 Dec 1;86(11):1279-81, A9
pubmed: 11090811
Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):e1-e9
pubmed: 28916153
Cardiovasc Pathol. 2010 Sep-Oct;19(5):308-11
pubmed: 19747852
J Am Soc Echocardiogr. 2006 Feb;19(2):206-10
pubmed: 16455426
Expert Opin Drug Saf. 2012 Sep;11(5):739-51
pubmed: 22788850
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
Heart Vessels. 2007 Nov;22(6):393-7
pubmed: 18043997
Echo Res Pract. 2021 May 07;8(1):R1-R11
pubmed: 33793418
J Am Soc Echocardiogr. 1997 Apr;10(3):271-92
pubmed: 9109692
Compr Physiol. 2015 Jul 1;5(3):1517-40
pubmed: 26140726
N Engl J Med. 1991 Mar 21;324(12):808-15
pubmed: 1997853
Cancers (Basel). 2021 Dec 23;14(1):
pubmed: 35008222
Eur Heart J. 2016 Sep 21;37(36):2768-2801
pubmed: 27567406
Eur Heart J Cardiovasc Imaging. 2017 May 1;18(8):930-936
pubmed: 28379383
Echocardiography. 2017 Nov;34(11):1593-1600
pubmed: 28942608
Expert Rev Mol Diagn. 2017 Mar;17(3):245-256
pubmed: 28092472

Auteurs

Agata Puzzovivo (A)

Cardioncology Unit, IRCCS IstitutoTumori "Giovanni Paolo II", 70124 Bari, Italy.

Agnese Maria Fioretti (AM)

Cardioncology Unit, IRCCS IstitutoTumori "Giovanni Paolo II", 70124 Bari, Italy.

Carla Minoia (C)

Hematology Unit, IRCCS IstitutoTumori "Giovanni Paolo II", 70124 Bari, Italy.

Roberta Villoni (R)

Cardioncology Unit, IRCCS IstitutoTumori "Giovanni Paolo II", 70124 Bari, Italy.

Santa Carbonara (S)

Section of Cardiovascular Diseases, Department of Emergency and Organ Transplantation (DETO), University Policlinic Hospital, 70124 Bari, Italy.

Giusi Graziano (G)

Scientific Direction, IRCCS IstitutoTumori "Giovanni Paolo II", 70124 Bari, Italy.

Fabio Pavone (F)

Hematology Unit, IRCCS IstitutoTumori "Giovanni Paolo II", 70124 Bari, Italy.

Attilio Guarini (A)

Hematology Unit, IRCCS IstitutoTumori "Giovanni Paolo II", 70124 Bari, Italy.

Stefano Oliva (S)

Cardioncology Unit, IRCCS IstitutoTumori "Giovanni Paolo II", 70124 Bari, Italy.

Classifications MeSH